Affymax (AFFY) shares halted amid headline the company has won approval for its anemia drug
Tweet
Share
E-mailGet Alerts AFFY Hot Sheet
Join SI Premium – FREE
Affymax (Nasdaq: AFFY) shares halted amid headline the company has won approval for its anemia drug.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abeona Therapeutics (ABEO) Receives FDA Complete Response Letter on Pz-cel
- Regeneron (REGN) and Mammoth Biosciences Collaborate over Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
- Traders Push Back Timing Of First Fed Rate Cut To December - Bloomberg
Create E-mail Alert Related Categories
FDA, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
